231 related articles for article (PubMed ID: 26139305)
1. The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy.
Mantzaris GJ; Tsironikos D; Tzanetakou X; Grispou E; Karatzas P; Kalogeropoulos I; Papamichael K
Scand J Gastroenterol; 2015; 50(12):1451-5. PubMed ID: 26139305
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients.
Andrisani G; Armuzzi A; Papa A; Marzo M; Felice C; Pugliese D; De Vitis I; Rapaccini GL; Guidi L
J Gastrointestin Liver Dis; 2013 Mar; 22(1):21-5. PubMed ID: 23539386
[TBL] [Abstract][Full Text] [Related]
3. QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States.
Qumseya BJ; Ananthakrishnan AN; Skaros S; Bonner M; Issa M; Zadvornova Y; Naik A; Perera L; Binion DG
Inflamm Bowel Dis; 2011 Jan; 17(1):77-83. PubMed ID: 20848501
[TBL] [Abstract][Full Text] [Related]
4. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
6. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
[TBL] [Abstract][Full Text] [Related]
7. Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases.
Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Novacek G; Vogelsang H; Dejaco C; Reinisch W
Inflamm Bowel Dis; 2011 Jan; 17(1):84-90. PubMed ID: 20722065
[TBL] [Abstract][Full Text] [Related]
8. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
[TBL] [Abstract][Full Text] [Related]
9. Use of Quantiferon-TB-Gold in Tube(®) test for detecting latent tuberculosis in patients considered as candidates for anti-TNF therapy in routine clinical practice.
García-Gasalla M; Fernández-Baca V; Juan-Mas A; Payeras-Cifre A; Cifuentes-Luna C; Taberner-Ferrer R; Riera-Oliver J; Ros-Villamajó I; Navarro-Fernández V; Morey Torrandell C; Gallegos-Alvarez C; Mir-Villadrich I
Enferm Infecc Microbiol Clin; 2013 Feb; 31(2):76-81. PubMed ID: 22902246
[TBL] [Abstract][Full Text] [Related]
10. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.
Bélard E; Semb S; Ruhwald M; Werlinrud AM; Soborg B; Jensen FK; Thomsen H; Brylov A; Hetland ML; Nordgaard-Lassen I; Ravn P
Inflamm Bowel Dis; 2011 Nov; 17(11):2340-9. PubMed ID: 21319275
[TBL] [Abstract][Full Text] [Related]
11. The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patients.
Abreu C; Almeida F; Ferraz R; Dias CC; Sarmento A; Magro F
Dig Liver Dis; 2016 Dec; 48(12):1438-1443. PubMed ID: 27599804
[TBL] [Abstract][Full Text] [Related]
12. QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.
Lee H; Park HY; Jeon K; Jeong BH; Hwang JW; Lee J; Cha HS; Koh EM; Kang ES; Koh WJ
PLoS One; 2015; 10(3):e0119260. PubMed ID: 25746854
[TBL] [Abstract][Full Text] [Related]
13. T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease.
Arias-Guillén M; Riestra S; de Francisco R; Palacios JJ; Belda J; Escalante P; Pérez-Martínez I; Molinos LM; Garcia-Clemente M; Pando-Sandoval A; Rodrigo L; Prieto A; Martínez-Camblor P; Losada A; Casan P
Inflamm Bowel Dis; 2014 Feb; 20(2):329-38. PubMed ID: 24378597
[TBL] [Abstract][Full Text] [Related]
14. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
[TBL] [Abstract][Full Text] [Related]
15. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
16. Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting.
Saidenberg-Kermanac'h N; Semerano L; Naccache JM; Brauner M; Falgarone G; Dumont-Fischer D; Guillot X; Valeyre D; Boissier MC
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1307-14. PubMed ID: 22863801
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy.
Freund R; Granger B; Francois C; Carcelain G; Ravaud P; Mariette X; Fautrel B
Presse Med; 2018 Feb; 47(2):e9-e13. PubMed ID: 29478790
[TBL] [Abstract][Full Text] [Related]
18. Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease.
Taxonera C; Ponferrada Á; Bermejo F; Riestra S; Saro C; Martín-Arranz MD; Cabriada JL; Barreiro-de Acosta M; de Castro ML; López-Serrano P; Barrio J; Suarez C; Iglesias E; Argüelles-Arias F; Ferrer I; Marín-Jiménez I; Hernández-Camba A; Bastida G; Van Domselaar M; Martínez-Montiel P; Olivares D; Alba C; Gisbert JP;
J Crohns Colitis; 2017 Jul; 11(7):792-800. PubMed ID: 28333182
[TBL] [Abstract][Full Text] [Related]
19. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
